LAMOTRIGINE EXTENDED-RELEASE

LAMOTRIGINE EXTENDED-RELEASE was reported 72847 times

These side effects are most commonly reported by patients taking LAMOTRIGINE EXTENDED-RELEASE:

# Side effect Count
0 DRUG INEFFECTIVE 6369
1 SEIZURE 4360
2 TOXICITY TO VARIOUS AGENTS 4055
3 OFF LABEL USE 3588
4 DRUG INTERACTION 3308
5 COMPLETED SUICIDE 3096
6 FATIGUE 3079
7 DIZZINESS 3047
8 NAUSEA 3028
9 RASH 2945
10 FOETAL EXPOSURE DURING PREGNANCY 2803
11 HEADACHE 2763
12 SOMNOLENCE 2629
13 DEPRESSION 2458
14 VOMITING 2396
15 CONDITION AGGRAVATED 2358
16 ANXIETY 2199
17 PYREXIA 2086
18 EPILEPSY 1945
19 FALL 1918
20 INTENTIONAL OVERDOSE 1876
21 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1840
22 CONFUSIONAL STATE 1773
23 MATERNAL EXPOSURE DURING PREGNANCY 1768
24 OVERDOSE 1728
25 DIARRHOEA 1705
26 TREMOR 1677
27 INSOMNIA 1629
28 PAIN 1608
29 SUICIDAL IDEATION 1579
30 SUICIDE ATTEMPT 1498
31 CONVULSION 1470
32 PRODUCT USE IN UNAPPROVED INDICATION 1438
33 ASTHENIA 1400
34 MALAISE 1388
35 WEIGHT INCREASED 1387
36 DYSPNOEA 1348
37 EXPOSURE DURING PREGNANCY 1343
38 PRURITUS 1328
39 STEVENS-JOHNSON SYNDROME 1303
40 MEMORY IMPAIRMENT 1292
41 GAIT DISTURBANCE 1243
42 AGITATION 1193
43 PRODUCT SUBSTITUTION ISSUE 1172
44 GENERALISED TONIC-CLONIC SEIZURE 1122
45 ARTHRALGIA 1068
46 PNEUMONIA 1067
47 AGGRESSION 1055
48 FEELING ABNORMAL 1047
49 DEATH 1035
50 HYPOTENSION 1004
51 PRODUCT DOSE OMISSION ISSUE 980
52 WEIGHT DECREASED 979
53 BALANCE DISORDER 971
54 TOXIC EPIDERMAL NECROLYSIS 968
55 DRUG HYPERSENSITIVITY 924
56 DECREASED APPETITE 920
57 HYPERTENSION 919
58 CARDIAC ARREST 909
59 LOSS OF CONSCIOUSNESS 890
60 ABDOMINAL PAIN UPPER 857
61 IRRITABILITY 853
62 COMA 837
63 HYPOAESTHESIA 831
64 URTICARIA 820
65 MUSCLE SPASMS 808
66 TREATMENT FAILURE 805
67 PARAESTHESIA 804
68 MIGRAINE 792
69 PRODUCT USE ISSUE 787
70 TACHYCARDIA 778
71 ABDOMINAL PAIN 772
72 ATAXIA 768
73 VISION BLURRED 759
74 ALOPECIA 747
75 HYPERSENSITIVITY 745
76 SLEEP DISORDER 744
77 CONSTIPATION 742
78 STATUS EPILEPTICUS 733
79 CARDIO-RESPIRATORY ARREST 730
80 DRUG ABUSE 723
81 PAIN IN EXTREMITY 719
82 DISTURBANCE IN ATTENTION 714
83 GENERAL PHYSICAL HEALTH DETERIORATION 704
84 BLISTER 700
85 ABORTION SPONTANEOUS 697
86 COGNITIVE DISORDER 696
87 ACUTE KIDNEY INJURY 686
88 GASTROOESOPHAGEAL REFLUX DISEASE 675
89 DRUG INTOLERANCE 674
90 ERYTHEMA 670
91 DRUG LEVEL INCREASED 664
92 SEROTONIN SYNDROME 658
93 PERIPHERAL SWELLING 652
94 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 648
95 PRODUCT QUALITY ISSUE 639
96 DRY MOUTH 629
97 DRUG EXPOSURE DURING PREGNANCY 627
98 INTENTIONAL SELF-INJURY 625
99 URINARY TRACT INFECTION 622
100 MUSCULAR WEAKNESS 617
101 ABDOMINAL DISCOMFORT 615
102 COUGH 608
103 AMNESIA 602
104 ELECTROCARDIOGRAM QT PROLONGED 599
105 HEPATIC ENZYME INCREASED 588
106 DEPRESSED MOOD 583
107 BACK PAIN 577
108 CHEST PAIN 576
109 RASH MACULO-PAPULAR 570
110 HALLUCINATION 562
111 VERTIGO 554
112 SEDATION 553
113 NASOPHARYNGITIS 549
114 DEPRESSED LEVEL OF CONSCIOUSNESS 548
115 MULTIPLE-DRUG RESISTANCE 521
116 LETHARGY 517
117 DYSARTHRIA 513
118 ABNORMAL BEHAVIOUR 509
119 HYPERHIDROSIS 508
120 LYMPHADENOPATHY 508
121 VISUAL IMPAIRMENT 507
122 ADVERSE DRUG REACTION 506
123 DYSKINESIA 506
124 HYPONATRAEMIA 501
125 C-REACTIVE PROTEIN INCREASED 495
126 PSYCHOTIC DISORDER 491
127 ATRIAL SEPTAL DEFECT 490
128 DIPLOPIA 488
129 ANGER 481
130 INTENTIONAL PRODUCT USE ISSUE 481
131 MANIA 473
132 THROMBOCYTOPENIA 459
133 DYSPHAGIA 455
134 CONTUSION 454
135 MYALGIA 452
136 STOMATITIS 448
137 SPEECH DISORDER 437
138 MYOCLONUS 436
139 COVID-19 434
140 MEDICATION ERROR 433
141 DRUG RESISTANCE 431
142 NEUTROPENIA 430
143 RESTLESSNESS 430
144 TREATMENT NONCOMPLIANCE 429
145 NECK PAIN 426
146 SWELLING 426
147 DISORIENTATION 425
148 ANAEMIA 422
149 DYSPEPSIA 421
150 DELIRIUM 414
151 PETIT MAL EPILEPSY 410
152 THERAPEUTIC PRODUCT EFFECT DECREASED 407
153 DEHYDRATION 404
154 INTENTIONAL PRODUCT MISUSE 404
155 JOINT SWELLING 404
156 OROPHARYNGEAL PAIN 403
157 RENAL FAILURE 403
158 RHABDOMYOLYSIS 402
159 RASH ERYTHEMATOUS 401
160 MOOD SWINGS 399
161 ALANINE AMINOTRANSFERASE INCREASED 398
162 ENCEPHALOPATHY 398
163 MUSCULOSKELETAL STIFFNESS 398
164 BLEPHAROSPASM 396
165 GAIT INABILITY 394
166 MENTAL DISORDER 394
167 NIGHT SWEATS 389
168 INCORRECT DOSE ADMINISTERED 388
169 PSORIATIC ARTHROPATHY 384
170 BLOOD CHOLESTEROL INCREASED 383
171 WITHDRAWAL SYNDROME 383
172 GLOSSODYNIA 382
173 RHEUMATOID ARTHRITIS 379
174 INFLAMMATION 378
175 BIPOLAR DISORDER 377
176 CHILLS 377
177 DRUG-INDUCED LIVER INJURY 377
178 INJURY 377
179 PALPITATIONS 376
180 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 373
181 OBESITY 370
182 TYPE 2 DIABETES MELLITUS 370
183 INFUSION RELATED REACTION 369
184 BRADYCARDIA 367
185 GASTROINTESTINAL DISORDER 367
186 MOBILITY DECREASED 367
187 HOSPITALISATION 364
188 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 364
189 INFECTION 364
190 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 364
191 UNRESPONSIVE TO STIMULI 362
192 IMPAIRED HEALING 358
193 TASTE DISORDER 357
194 CONTRAINDICATED PRODUCT ADMINISTERED 356
195 SYSTEMIC LUPUS ERYTHEMATOSUS 356
196 SYNCOPE 354
197 THERAPY NON-RESPONDER 354
198 ASTHMA 352
199 NYSTAGMUS 352
200 PARTIAL SEIZURES 352
201 HEART RATE INCREASED 351
202 BLOOD PRESSURE INCREASED 345
203 SKIN EXFOLIATION 344
204 IRRITABLE BOWEL SYNDROME 343
205 APHASIA 340
206 CRYING 338
207 FOLLICULITIS 335
208 RESPIRATORY ARREST 334
209 FIBROMYALGIA 332
210 MATERNAL DRUGS AFFECTING FOETUS 332
211 MOOD ALTERED 332
212 MUSCLE TWITCHING 332
213 OEDEMA PERIPHERAL 332
214 LEUKOPENIA 331
215 OSTEOARTHRITIS 331
216 ALTERED STATE OF CONSCIOUSNESS 330
217 CHRONIC KIDNEY DISEASE 330
218 BURSITIS 324
219 PERICARDITIS 324
220 MENTAL STATUS CHANGES 321
221 LUNG DISORDER 318
222 NEUROLEPTIC MALIGNANT SYNDROME 318
223 SWELLING FACE 318
224 WHITE BLOOD CELL COUNT DECREASED 317
225 MUSCULOSKELETAL PAIN 316
226 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 315
227 ABDOMINAL DISTENSION 314
228 SEPSIS 314
229 BACK INJURY 313
230 DRUG ERUPTION 312
231 LIVER INJURY 312
232 HALLUCINATION, VISUAL 311
233 RASH PRURITIC 311
234 EMOTIONAL DISTRESS 310
235 PREMATURE BABY 310
236 STRESS 310
237 MENTAL IMPAIRMENT 309
238 PANIC ATTACK 305
239 NIGHTMARE 304
240 UNDERDOSE 303
241 SINUSITIS 301
242 WHEEZING 301
243 HALLUCINATION, AUDITORY 300
244 LIVE BIRTH 300
245 VENTRICULAR SEPTAL DEFECT 300
246 WOUND 299
247 RESPIRATORY FAILURE 298
248 BREAST CANCER STAGE III 297
249 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 297
250 ILLNESS 297
251 ARTHROPATHY 296
252 ADVERSE EVENT 295
253 LOWER RESPIRATORY TRACT INFECTION 294
254 OXYGEN SATURATION DECREASED 294
255 SYNOVITIS 294
256 HYPERCHOLESTEROLAEMIA 293
257 GRAND MAL CONVULSION 292
258 INFLUENZA LIKE ILLNESS 292
259 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 292
260 SUSPECTED SUICIDE 291
261 DUODENAL ULCER PERFORATION 287
262 LIVER FUNCTION TEST INCREASED 287
263 ASPARTATE AMINOTRANSFERASE INCREASED 284
264 POISONING 283
265 DISEASE RECURRENCE 279
266 PERIPHERAL VENOUS DISEASE 279
267 FACET JOINT SYNDROME 278
268 MULTIPLE ORGAN DYSFUNCTION SYNDROME 277
269 DRUG DOSE OMISSION 276
270 PLATELET COUNT DECREASED 276
271 HYPERSOMNIA 275
272 INJECTION SITE PAIN 274
273 EOSINOPHILIA 273
274 FLUSHING 273
275 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 271
276 PSYCHOMOTOR HYPERACTIVITY 270
277 FEELING HOT 269
278 DELUSION 268
279 THERAPEUTIC RESPONSE DECREASED 261
280 HELICOBACTER INFECTION 260
281 BLOOD CREATINE PHOSPHOKINASE INCREASED 258
282 COORDINATION ABNORMAL 258
283 PEMPHIGUS 256
284 CEREBROVASCULAR ACCIDENT 254
285 MUSCLE INJURY 254
286 WHITE BLOOD CELL COUNT INCREASED 254
287 OBSESSIVE-COMPULSIVE DISORDER 253
288 URINARY INCONTINENCE 253
289 HAND DEFORMITY 252
290 POISONING DELIBERATE 252
291 ILL-DEFINED DISORDER 251
292 SINUS TACHYCARDIA 251
293 METABOLIC ACIDOSIS 247
294 INFLUENZA 245
295 CONGENITAL ANOMALY 244
296 PARANOIA 244
297 PSORIASIS 243
298 AKATHISIA 241
299 WOUND INFECTION 241
300 PNEUMONIA ASPIRATION 240
301 DISCOMFORT 239
302 OEDEMA 239
303 RASH MACULAR 239
304 ACCIDENTAL OVERDOSE 238
305 HEAD INJURY 238
306 PANCREATITIS 237
307 RASH GENERALISED 237
308 LIP DRY 236
309 CHEST DISCOMFORT 235
310 JOINT RANGE OF MOTION DECREASED 235
311 DRUG WITHDRAWAL SYNDROME 233
312 BLOOD GLUCOSE INCREASED 230
313 PANCYTOPENIA 230
314 EXTRAPYRAMIDAL DISORDER 227
315 HYPOKALAEMIA 226
316 THINKING ABNORMAL 221
317 BURNING SENSATION 219
318 OSTEOPOROSIS 219
319 ONYCHOMADESIS 218
320 PREGNANCY 216
321 MYDRIASIS 215
322 PRESCRIBED OVERDOSE 213
323 LIVER DISORDER 212
324 TARDIVE DYSKINESIA 212
325 PHOTOPHOBIA 211
326 BLOOD PRESSURE DECREASED 209
327 HAEMOGLOBIN DECREASED 209
328 INFUSION SITE REACTION 208
329 DRUG DEPENDENCE 207
330 TRANSAMINASES INCREASED 207
331 UNEVALUABLE EVENT 207
332 BEHAVIOUR DISORDER 206
333 NERVOUSNESS 206
334 PATENT DUCTUS ARTERIOSUS 206
335 RHEUMATIC FEVER 206
336 BRONCHITIS 205
337 FACE OEDEMA 205
338 URINARY RETENTION 205
339 APATHY 204
340 EMOTIONAL DISORDER 204
341 DYSTONIA 203
342 MOUTH ULCERATION 203
343 MUSCLE RIGIDITY 202
344 NO ADVERSE EVENT 202
345 ROAD TRAFFIC ACCIDENT 202
346 RENAL IMPAIRMENT 200
347 TINNITUS 200
348 DIABETES MELLITUS 199
349 EYE PAIN 199
350 DRUG LEVEL DECREASED 198
351 DYSGEUSIA 198
352 ARRHYTHMIA 197
353 CONJUNCTIVITIS 196
354 PULMONARY EMBOLISM 196
355 SHOCK 196
356 MYOCARDIAL INFARCTION 195
357 HYPOSPADIAS 193
358 LEUKOCYTOSIS 193
359 MOVEMENT DISORDER 193
360 BODY TEMPERATURE INCREASED 191
361 DRY SKIN 190
362 FEAR 190
363 AGRANULOCYTOSIS 189
364 DYSMORPHISM 189
365 PRESCRIBED UNDERDOSE 189
366 EXPOSURE VIA BREAST MILK 186
367 NAIL DISORDER 185
368 SPINA BIFIDA 185
369 NEUROPATHY PERIPHERAL 183
370 RASH PAPULAR 182
371 SKIN LESION 182
372 HYPOTONIA 181
373 MATERNAL EXPOSURE DURING BREAST FEEDING 181
374 SOPOR 181
375 THERAPY INTERRUPTED 181
376 HEPATIC FUNCTION ABNORMAL 180
377 HYPOMANIA 180
378 SEPTIC SHOCK 180
379 SLEEP APNOEA SYNDROME 180
380 GAMMA-GLUTAMYLTRANSFERASE INCREASED 178
381 SURGERY 178
382 PARKINSONISM 177
383 LIP SWELLING 175
384 HYPOTHYROIDISM 174
385 BLOOD CREATININE INCREASED 173
386 HYPERREFLEXIA 173
387 POOR QUALITY SLEEP 172
388 SMALL FOR DATES BABY 172
389 THERAPEUTIC RESPONSE UNEXPECTED 172
390 CAESAREAN SECTION 171
391 ACUTE RESPIRATORY DISTRESS SYNDROME 169
392 ABORTION INDUCED 168
393 ACUTE HEPATIC FAILURE 168
394 EXOSTOSIS 168
395 DISSEMINATED INTRAVASCULAR COAGULATION 167
396 PRODUCT DOSE OMISSION 167
397 RED BLOOD CELL SEDIMENTATION RATE INCREASED 167
398 MULTIPLE SCLEROSIS RELAPSE 166
399 PLEURAL EFFUSION 166
400 SKIN DISCOLOURATION 166
401 ARTHRITIS 165
402 EAR PAIN 165
403 ECZEMA 165
404 ERYTHEMA MULTIFORME 165
405 THERAPY CESSATION 165
406 HEPATIC FAILURE 164
407 RESTLESS LEGS SYNDROME 164
408 DYSURIA 163
409 HAEMORRHAGE 163
410 HEPATITIS 163
411 ANHEDONIA 162
412 TALIPES 160
413 UPPER RESPIRATORY TRACT INFECTION 160
414 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 158
415 MIDDLE INSOMNIA 158
416 SALIVARY HYPERSECRETION 158
417 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 158
418 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 157
419 LIVER FUNCTION TEST ABNORMAL 157
420 CELLULITIS 156
421 SWOLLEN TONGUE 156
422 ELECTROENCEPHALOGRAM ABNORMAL 155
423 MYOCLONIC EPILEPSY 155
424 RESPIRATORY DISORDER 154
425 IMPAIRED WORK ABILITY 153
426 NEPHROLITHIASIS 153
427 EAR INFECTION 151
428 AFFECTIVE DISORDER 150
429 HYPERTHERMIA 150
430 INCREASED APPETITE 150
431 HYPOGAMMAGLOBULINAEMIA 149
432 OCULAR HYPERAEMIA 149
433 DEVELOPMENTAL DELAY 148
434 ATRIAL FIBRILLATION 147
435 NERVOUS SYSTEM DISORDER 147
436 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 146
437 ACNE 144
438 DRY EYE 144
439 GRIP STRENGTH DECREASED 143
440 NEUTROPHIL COUNT DECREASED 143
441 CARDIAC DISORDER 142
442 RESPIRATORY DEPRESSION 142
443 THROMBOSIS 142
444 HOT FLUSH 141
445 RESPIRATORY DISORDER NEONATAL 141
446 EPISTAXIS 140
447 OCULOGYRIC CRISIS 140
448 PRODUCT PRESCRIBING ERROR 139
449 RHINORRHOEA 139
450 ANGIOEDEMA 137
451 NEUROTOXICITY 137
452 PREMATURE DELIVERY 136
453 HYPERAMMONAEMIA 135
454 SCHIZOPHRENIA 135
455 FREQUENT BOWEL MOVEMENTS 134
456 HYPOGLYCAEMIA 133
457 MYOCARDITIS 133
458 MENINGITIS ASEPTIC 132
459 PALLOR 132
460 PHOTOSENSITIVITY REACTION 132
461 AFFECT LABILITY 130
462 ANTICONVULSANT DRUG LEVEL INCREASED 130
463 AUTISM SPECTRUM DISORDER 130
464 CROHN^S DISEASE 130
465 DYSPHONIA 130
466 MULTIPLE SCLEROSIS 130
467 RESPIRATORY DISTRESS 130
468 THROAT TIGHTNESS 130
469 TUBULOINTERSTITIAL NEPHRITIS 130
470 ANTICONVULSANT DRUG LEVEL DECREASED 129
471 DRUG TOXICITY 129
472 HYPOPHAGIA 129
473 HYPOXIA 129
474 LOWER LIMB FRACTURE 129
475 PSYCHIATRIC SYMPTOM 129
476 TOXIC SKIN ERUPTION 129
477 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 128
478 ABNORMAL DREAMS 127
479 BRAIN FOG 127
480 EYE IRRITATION 127
481 BRAIN OEDEMA 126
482 CLONUS 126
483 JOINT STIFFNESS 126
484 MAJOR DEPRESSION 126
485 CATATONIA 125
486 DERMATITIS ATOPIC 125
487 FEELING DRUNK 125
488 POLLAKIURIA 125
489 APNOEA 124
490 CONCUSSION 124
491 NEONATAL RESPIRATORY DISTRESS SYNDROME 124
492 VENTRICULAR TACHYCARDIA 124
493 CARDIAC FAILURE 123
494 FOCAL DYSCOGNITIVE SEIZURES 122
495 NORMAL NEWBORN 122
496 PRODUCT ADMINISTRATION ERROR 122
497 SKIN BURNING SENSATION 122
498 THERAPY PARTIAL RESPONDER 122
499 CIRCULATORY COLLAPSE 121
500 DISLOCATION OF VERTEBRA 121
501 PRODUCT ADMINISTRATION INTERRUPTED 120
502 RASH MORBILLIFORM 120
503 RIB FRACTURE 120
504 STILLBIRTH 119
505 CATARACT 118
506 DISABILITY 118
507 DISSOCIATION 118
508 OVERLAP SYNDROME 118
509 BLINDNESS 117
510 EATING DISORDER 117
511 TACHYPNOEA 117
512 VENTRICULAR FIBRILLATION 117
513 CHOLESTASIS 116
514 DEPRESSIVE SYMPTOM 116
515 DISEASE PROGRESSION 116
516 FOOT FRACTURE 116
517 HYPERTONIA 116
518 IMPAIRED GASTRIC EMPTYING 116
519 INTENTIONAL DOSE OMISSION 116
520 PRODUCT DISPENSING ERROR 116
521 PSYCHOMOTOR RETARDATION 116
522 ACCIDENTAL EXPOSURE TO PRODUCT 115
523 CLEFT PALATE 115
524 CEREBRAL ATROPHY 114
525 DRUG EFFECT DECREASED 114
526 ANAPHYLACTIC REACTION 113
527 AURA 113
528 DEMENTIA 113
529 FLATULENCE 112
530 HEPATIC STEATOSIS 112
531 BLOOD POTASSIUM DECREASED 111
532 BONE PAIN 111
533 DEEP VEIN THROMBOSIS 111
534 EYE MOVEMENT DISORDER 111
535 BLOOD ALKALINE PHOSPHATASE INCREASED 110
536 DERMATITIS ALLERGIC 110
537 DYSSTASIA 110
538 JAUNDICE 110
539 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 110
540 HAEMODYNAMIC INSTABILITY 109
541 LOW BIRTH WEIGHT BABY 109
542 ANTIPSYCHOTIC DRUG LEVEL INCREASED 108
543 BLOOD SODIUM DECREASED 107
544 HEPATOCELLULAR INJURY 107
545 LARYNGITIS 107
546 LUPUS-LIKE SYNDROME 107
547 PERSONALITY CHANGE 107
548 CARDIOGENIC SHOCK 106
549 HERPES ZOSTER 106
550 PRODUCTIVE COUGH 106
551 DROOLING 105
552 LIMB DISCOMFORT 105
553 SKIN DISORDER 105
554 TONIC CONVULSION 105
555 ORAL DISORDER 104
556 EYE SWELLING 103
557 HEPATIC CIRRHOSIS 103
558 RASH VESICULAR 103
559 RED BLOOD CELL COUNT DECREASED 103
560 SCIATICA 103
561 SWOLLEN JOINT COUNT INCREASED 103
562 BREAST CANCER STAGE II 102
563 INJECTION SITE ERYTHEMA 102
564 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 101
565 MOTOR DYSFUNCTION 101
566 PULMONARY OEDEMA 101
567 WRONG PATIENT RECEIVED PRODUCT 101
568 AUTOIMMUNE DISORDER 100
569 PRODUCT PRESCRIBING ISSUE 100
570 RENAL FAILURE ACUTE 100
571 NEUTROPHIL COUNT INCREASED 99
572 SELECTIVE EATING DISORDER 99
573 CONJUNCTIVAL HYPERAEMIA 98
574 DRUG TOLERANCE 98
575 FEELING JITTERY 98
576 GESTATIONAL DIABETES 98
577 POLYDACTYLY 98
578 ASPIRATION 97
579 DEVELOPMENTAL HIP DYSPLASIA 97
580 MIOSIS 97
581 NASAL CONGESTION 97
582 DRUG DISPENSING ERROR 96
583 FLUID RETENTION 96
584 INJECTION SITE REACTION 96
585 INTERNATIONAL NORMALISED RATIO INCREASED 96
586 MATERNAL EXPOSURE BEFORE PREGNANCY 96
587 TIC 96
588 BRUGADA SYNDROME 95
589 CENTRAL NERVOUS SYSTEM LESION 95
590 DRUG EFFECT INCOMPLETE 95
591 ECONOMIC PROBLEM 95
592 EYE DISORDER 95
593 HYPOTHERMIA 95
594 THIRST 95
595 VIRAL INFECTION 95
596 DECREASED INTEREST 94
597 FEEDING DISORDER 94
598 INTESTINAL OBSTRUCTION 94
599 PRODUCT AVAILABILITY ISSUE 94
600 BLOOD PROLACTIN INCREASED 93
601 EUPHORIC MOOD 93
602 HYPERNATRAEMIA 93
603 HYPOTONIA NEONATAL 93
604 LUPUS VULGARIS 93
605 PLEUROTHOTONUS 93
606 RENAL DISORDER 93
607 STAPHYLOCOCCAL INFECTION 93
608 SUICIDAL BEHAVIOUR 93
609 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 92
610 CEREBRAL DISORDER 92
611 CHOKING 92
612 CYSTITIS 92
613 COMA SCALE ABNORMAL 91
614 HAEMATOCHEZIA 91
615 HYPOACUSIS 91
616 IMPAIRED DRIVING ABILITY 91
617 INJECTION SITE BRUISING 91
618 JOINT INJURY 90
619 OSTEOPENIA 90
620 RESPIRATORY ACIDOSIS 90
621 ACUTE RESPIRATORY FAILURE 89
622 BONE EROSION 89
623 FOETAL ANTICONVULSANT SYNDROME 89
624 GASTROINTESTINAL HAEMORRHAGE 89
625 MULTI-ORGAN FAILURE 89
626 SINUS BRADYCARDIA 89
627 BEZOAR 88
628 SKIN REACTION 88
629 VISUAL ACUITY REDUCED 88
630 COARCTATION OF THE AORTA 87
631 DEVICE ISSUE 87
632 HYPOKINESIA 87
633 INITIAL INSOMNIA 87
634 PAPULE 87
635 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 86
636 HEMIPARESIS 86
637 INTERSTITIAL LUNG DISEASE 86
638 PANCREATITIS ACUTE 86
639 RECTAL HAEMORRHAGE 86
640 SCAR 86
641 SUDDEN DEATH 86
642 TACHYPHRENIA 86
643 LIMB INJURY 85
644 ORAL PAIN 85
645 BUNDLE BRANCH BLOCK RIGHT 84
646 FEELING COLD 84
647 IMPULSIVE BEHAVIOUR 84
648 INTENTIONAL DRUG MISUSE 84
649 PARADOXICAL DRUG REACTION 84
650 PERICARDIAL EFFUSION 84
651 PERSONALITY DISORDER 84
652 CEREBELLAR SYNDROME 83
653 CYANOSIS 83
654 INTELLECTUAL DISABILITY 83
655 OVERWEIGHT 83
656 PHARYNGITIS 83
657 PRODUCT DOSE OMISSION IN ERROR 83
658 PULMONARY FIBROSIS 83
659 PURPURA 83
660 VAGINAL HAEMORRHAGE 83
661 BIPOLAR I DISORDER 82
662 BLOOD BILIRUBIN INCREASED 82
663 BRADYCARDIA NEONATAL 82
664 CANDIDA INFECTION 82
665 CLEFT LIP AND PALATE 82
666 HEART RATE DECREASED 82
667 HEPATIC CYTOLYSIS 82
668 HIP FRACTURE 82
669 SELF-INJURIOUS IDEATION 82
670 THERAPEUTIC RESPONSE CHANGED 82
671 VITAMIN D DEFICIENCY 82
672 ERECTILE DYSFUNCTION 81
673 GAZE PALSY 81
674 INFARCTION 81
675 NEURALGIA 81
676 SPEECH DISORDER DEVELOPMENTAL 81
677 ACIDOSIS 80
678 AGITATION NEONATAL 80
679 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 80
680 DERMATITIS 80
681 HAEMATOMA 80
682 HYPERGLYCAEMIA 80
683 INJECTION SITE SWELLING 80
684 LYMPHOPENIA 80
685 FOETAL MALFORMATION 79
686 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 79
687 SJS-TEN OVERLAP 79
688 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 78
689 EYELID OEDEMA 78
690 HALLUCINATIONS, MIXED 78
691 LABORATORY TEST ABNORMAL 78
692 ORTHOSTATIC HYPOTENSION 78
693 PSYCHOMOTOR SKILLS IMPAIRED 78
694 RETCHING 78
695 SCREAMING 78
696 ATRIOVENTRICULAR BLOCK COMPLETE 77
697 DRUG LEVEL ABOVE THERAPEUTIC 77
698 INTERVERTEBRAL DISC PROTRUSION 77
699 JOINT DISLOCATION 77
700 ORAL MUCOSAL BLISTERING 77
701 RHEUMATOID FACTOR POSITIVE 77
702 ATONIC SEIZURES 76
703 FEEDING DISORDER NEONATAL 76
704 LOGORRHOEA 76
705 MUSCLE TIGHTNESS 76
706 PRE-EXISTING CONDITION IMPROVED 76
707 QUALITY OF LIFE DECREASED 76
708 STRABISMUS 76
709 ADVERSE REACTION 75
710 BLOOD LACTATE DEHYDROGENASE INCREASED 75
711 COELIAC DISEASE 75
712 LYMPHOCYTE COUNT DECREASED 75
713 SENSORY DISTURBANCE 75
714 SOCIAL AVOIDANT BEHAVIOUR 75
715 TRANSIENT ISCHAEMIC ATTACK 75
716 ANURIA 74
717 BRAIN INJURY 74
718 COMPLEX PARTIAL SEIZURES 74
719 DEEP VEIN THROMBOSIS POSTOPERATIVE 74
720 PARKINSON^S DISEASE 74
721 PERSECUTORY DELUSION 74
722 THERAPEUTIC RESPONSE SHORTENED 74
723 BREAST CANCER 73
724 DRUG ADMINISTRATION ERROR 73
725 ELECTROCARDIOGRAM ABNORMAL 73
726 KNEE ARTHROPLASTY 73
727 MICROCEPHALY 73
728 MUCOSAL INFLAMMATION 73
729 POST-TRAUMATIC STRESS DISORDER 73
730 PSYCHOTIC SYMPTOM 73
731 UPPER LIMB FRACTURE 73
732 FEBRILE NEUTROPENIA 72
733 GASTRITIS 72
734 HAEMATOCRIT DECREASED 72
735 HOSTILITY 72
736 RETINITIS 72
737 STARING 72
738 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 71
739 ATRIOVENTRICULAR BLOCK 71
740 BEDRIDDEN 71
741 CARDIAC MURMUR 71
742 DISTRIBUTIVE SHOCK 71
743 FOETAL GROWTH RESTRICTION 71
744 LACTIC ACIDOSIS 71
745 MENORRHAGIA 71
746 PRE-ECLAMPSIA 71
747 SCAB 71
748 SOMNAMBULISM 71
749 ANXIETY DISORDER 70
750 DRUG LEVEL BELOW THERAPEUTIC 70
751 FEELING OF DESPAIR 70
752 GASTROENTERITIS VIRAL 70
753 PLATELET COUNT INCREASED 70
754 SPLENOMEGALY 70
755 THROAT IRRITATION 70
756 ABASIA 69
757 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 69
758 BACTERIAL INFECTION 69
759 BRUXISM 69
760 DEAFNESS 69
761 EOSINOPHILIC MYOCARDITIS 69
762 EYE PRURITUS 69
763 GASTRIC DISORDER 69
764 HYPERVENTILATION 69
765 ORAL MUCOSA EROSION 69
766 TOXIC ENCEPHALOPATHY 69
767 ULCER HAEMORRHAGE 69
768 CARDIOTOXICITY 68
769 CHOLELITHIASIS 68
770 HUNGER 68
771 HYPERTRANSAMINASAEMIA 68
772 INJECTION SITE PRURITUS 68
773 PRESYNCOPE 68
774 RENAL INJURY 68
775 STRESS CARDIOMYOPATHY 68
776 TORSADE DE POINTES 68
777 ABDOMINAL PAIN LOWER 67
778 BRADYKINESIA 67
779 FINE MOTOR SKILL DYSFUNCTION 67
780 HYPOCALCAEMIA 67
781 ODYNOPHAGIA 67
782 PRODUCT PHYSICAL ISSUE 67
783 STUPOR 67
784 COLITIS ULCERATIVE 66
785 DEVICE DISLOCATION 66
786 EXPOSURE VIA INGESTION 66
787 INCONTINENCE 66
788 INFANTILE APNOEA 66
789 INJECTION SITE HAEMORRHAGE 66
790 SEXUAL DYSFUNCTION 66
791 SPINAL FRACTURE 66
792 X-RAY ABNORMAL 66
793 CLUMSINESS 65
794 DRUG WITHDRAWAL SYNDROME NEONATAL 65
795 DYSPNOEA EXERTIONAL 65
796 GENERALISED ERYTHEMA 65
797 HEPATIC NECROSIS 65
798 IMPAIRED QUALITY OF LIFE 65
799 INSURANCE ISSUE 65
800 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 65
801 PERIPHERAL COLDNESS 65
802 ABNORMAL WEIGHT GAIN 64
803 ACTIVITIES OF DAILY LIVING IMPAIRED 64
804 ENURESIS 64
805 EXPOSURE DURING BREAST FEEDING 64
806 HYPOALBUMINAEMIA 64
807 INABILITY TO AFFORD MEDICATION 64
808 SNORING 64
809 ANKLE FRACTURE 63
810 COLITIS 63
811 DERMATITIS BULLOUS 63
812 HEPATOTOXICITY 63
813 HERNIA 63
814 NEOPLASM MALIGNANT 63
815 POLYDIPSIA 63
816 PRODUCT LABEL CONFUSION 63
817 RESPIRATORY TRACT INFECTION 63
818 BLOOD TRIGLYCERIDES INCREASED 62
819 C-REACTIVE PROTEIN ABNORMAL 62
820 CHROMATURIA 62
821 DRUG SCREEN POSITIVE 62
822 GAMBLING DISORDER 62
823 HAEMATURIA 62
824 HYPOCHOLESTEROLAEMIA 62
825 MENSTRUATION IRREGULAR 62
826 RESPIRATORY RATE INCREASED 62
827 DRUG TITRATION ERROR 61
828 EXCESSIVE EYE BLINKING 61
829 HEAD DISCOMFORT 61
830 HEPATOMEGALY 61
831 HYPOAESTHESIA ORAL 61
832 LIBIDO DECREASED 61
833 OBSESSIVE THOUGHTS 61
834 PARALYSIS 61
835 SYNDACTYLY 61
836 AMMONIA INCREASED 60
837 BACK DISORDER 60
838 BRADYPHRENIA 60
839 CHANGE IN SEIZURE PRESENTATION 60
840 HEART RATE IRREGULAR 60
841 NO THERAPEUTIC RESPONSE 60
842 UNINTENDED PREGNANCY 60
843 WRONG TECHNIQUE IN DRUG USAGE PROCESS 60
844 BLOOD PRESSURE FLUCTUATION 59
845 CARDIAC FAILURE CONGESTIVE 59
846 ELECTRIC SHOCK SENSATION 59
847 ELECTROLYTE IMBALANCE 59
848 HYPERBILIRUBINAEMIA 59
849 HYPERPHAGIA 59
850 LACRIMATION INCREASED 59
851 LIBIDO INCREASED 59
852 PETECHIAE 59
853 PYLORIC STENOSIS 59
854 SUBDURAL HAEMATOMA 59
855 WALKING AID USER 59
856 WRONG PRODUCT ADMINISTERED 59
857 ATTENTION DEFICIT HYPERACTIVITY DISORDER 58
858 FRACTURE 58
859 HEPATOSPLENOMEGALY 58
860 HIP ARTHROPLASTY 58
861 NEUTROPHILIA 58
862 TONIC CLONIC MOVEMENTS 58
863 APLASTIC ANAEMIA 57
864 ASCITES 57
865 CEREBRAL HAEMORRHAGE 57
866 FUNGAL INFECTION 57
867 ONYCHOMYCOSIS 57
868 PHARYNGEAL OEDEMA 57
869 PROTEINURIA 57
870 THERAPY CHANGE 57
871 ANAL INCONTINENCE 56
872 BLOOD PRESSURE ABNORMAL 56
873 BRADYPNOEA 56
874 CHEILITIS 56
875 DEVICE MALFUNCTION 56
876 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 56
877 HYPERLIPIDAEMIA 56
878 INJECTION SITE MASS 56
879 LIP EROSION 56
880 MALIGNANT NEOPLASM PROGRESSION 56
881 MITRAL VALVE INCOMPETENCE 56
882 NEUTROPENIC SEPSIS 56
883 PAIN IN JAW 56
884 PRURITUS GENERALISED 56
885 REBOUND EFFECT 56
886 SEIZURE CLUSTER 56
887 SLUGGISHNESS 56
888 TEMPERATURE REGULATION DISORDER 56
889 BLOOD GLUCOSE DECREASED 55
890 CARDIOMEGALY 55
891 ILLUSION 55
892 INCOHERENT 55
893 MULTIPLE DRUG OVERDOSE INTENTIONAL 55
894 OBSTRUCTIVE AIRWAYS DISORDER 55
895 PNEUMONITIS 55
896 SLOW SPEECH 55
897 TOOTHACHE 55
898 URINARY TRACT DISORDER 55
899 ARTERIOSCLEROSIS CORONARY ARTERY 54
900 DECREASED ACTIVITY 54
901 DEVICE BREAKAGE 54
902 DYSGRAPHIA 54
903 FOOT DEFORMITY 54
904 HYDRONEPHROSIS 54
905 HYPERACUSIS 54
906 TOOTH DISORDER 54
907 ULCER 54
908 CARPAL TUNNEL SYNDROME 53
909 END STAGE RENAL DISEASE 53
910 EXOMPHALOS 53
911 EYE DISCHARGE 53
912 HEMIPLEGIA 53
913 LEARNING DISORDER 53
914 MULTIPLE CONGENITAL ABNORMALITIES 53
915 NEUROLOGICAL SYMPTOM 53
916 PRODUCT TASTE ABNORMAL 53
917 SKIN FISSURES 53
918 VENTRICULAR EXTRASYSTOLES 53
919 BUNDLE BRANCH BLOCK LEFT 52
920 CLOSTRIDIUM DIFFICILE INFECTION 52
921 DEVICE EXPULSION 52
922 DISORGANISED SPEECH 52
923 DRUG PRESCRIBING ERROR 52
924 DRUG WITHDRAWAL CONVULSIONS 52
925 EOSINOPHIL COUNT INCREASED 52
926 HAEMATEMESIS 52
927 HEART DISEASE CONGENITAL 52
928 INAPPROPRIATE AFFECT 52
929 INCREASED TENDENCY TO BRUISE 52
930 MUSCLE SPASTICITY 52
931 STERNAL FRACTURE 52
932 SUBSTANCE ABUSE 52
933 ATELECTASIS 51
934 INFUSION SITE PAIN 51
935 KIDNEY INFECTION 51
936 POSTURE ABNORMAL 51
937 PREMATURE LABOUR 51
938 SELF-MEDICATION 51
939 TEMPERATURE INTOLERANCE 51
940 THERAPEUTIC PRODUCT CROSS-REACTIVITY 51
941 TONGUE BITING 51
942 BONE DENSITY DECREASED 50
943 COAGULOPATHY 50
944 DERMATITIS EXFOLIATIVE 50
945 DIABETIC KETOACIDOSIS 50
946 EXPIRED PRODUCT ADMINISTERED 50
947 HYPERKALAEMIA 50
948 HYPERPROLACTINAEMIA 50
949 OSTEONECROSIS 50
950 PRODUCT USE COMPLAINT 50
951 SKIN ULCER 50
952 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 49
953 DRUG SCREEN FALSE POSITIVE 49
954 HYPERTRIGLYCERIDAEMIA 49
955 SCRATCH 49
956 TOXIC OPTIC NEUROPATHY 49
957 TROPONIN INCREASED 49
958 WRIST FRACTURE 49
959 DYSMETRIA 48
960 DYSPHORIA 48
961 FACIAL PAIN 48
962 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 48
963 ORAL CANDIDIASIS 48
964 POOR FEEDING INFANT 48
965 PULSELESS ELECTRICAL ACTIVITY 48
966 SUPRAVENTRICULAR TACHYCARDIA 48
967 TENDERNESS 48
968 AREFLEXIA 47
969 CATAPLEXY 47
970 COLD SWEAT 47
971 DRUG USE DISORDER 47
972 EXTRA DOSE ADMINISTERED 47
973 HAEMATOLOGICAL INFECTION 47
974 HISTIOCYTOSIS HAEMATOPHAGIC 47
975 HYPOVOLAEMIC SHOCK 47
976 MATERNAL EXPOSURE TIMING UNSPECIFIED 47
977 MUSCLE ATROPHY 47
978 MYELOSUPPRESSION 47
979 PULMONARY HYPERTENSION 47
980 SOFT TISSUE INJURY 47
981 BLOOD PRESSURE SYSTOLIC INCREASED 46
982 ENCEPHALITIS 46
983 FAECES DISCOLOURED 46
984 FLAT AFFECT 46
985 FOETAL DEATH 46
986 HAEMODIALYSIS 46
987 HOMICIDAL IDEATION 46
988 IMMUNODEFICIENCY 46
989 NEW ONSET REFRACTORY STATUS EPILEPTICUS 46
990 POSTICTAL PSYCHOSIS 46
991 PUSTULAR PSORIASIS 46
992 VISUAL FIELD DEFECT 46
993 ACUTE MYOCARDIAL INFARCTION 45
994 BLOOD LACTIC ACID INCREASED 45
995 BONE MARROW FAILURE 45
996 CYST 45
997 DEPRESSION SUICIDAL 45
998 DRUG DOSE TITRATION NOT PERFORMED 45
999 DRUG EFFECT LESS THAN EXPECTED 45